Synthesis of the matrix metalloproteinases and its inhibitors by peripheral blood phagocytes of women with hypertansion disorders

Irina Aleksandrovna Panova; Anna Ivanovna Malyshkina; Anna Vladimirovna Kudryashova; Daria Aleksandrovna Khlipunova; Elena Arkadyevna Rockatanskaya; Lyudmila Alekseevna Sytova

doi:10.17816/JOWD64326-32

Journal of obstetrics and women's diseases ›› 2015, Vol. 64 ›› Issue (3) :26 -32. DOI: 10.17816/JOWD64326-32

Articles

research-article

Synthesis of the matrix metalloproteinases and its inhibitors by peripheral blood phagocytes of women with hypertansion disorders

Author information +

History +

PDF

Abstract

Development of the hypertension disorders in pregnant women is associated with the increase of the functional activity of innate immunity cells. RT-PCR assessment of the MMP-2 and TIMP-1 synthesis by peripheral blood phagocytes showed the significant elevation of the MMP-9 mRNA expression by neutrophils in women with chronic arterial hypertension (CAH) and TIMP-1 and TIMP-2 mRNA expression by monocytes in women with CAH and preeclampsia.

Keywords

pregnancy / hypertension disorders / matrix metalloproteinases / neutrophils / monocytes

Cite this article

Download citation ▾

Irina Aleksandrovna Panova, Anna Ivanovna Malyshkina, Anna Vladimirovna Kudryashova, Daria Aleksandrovna Khlipunova, Elena Arkadyevna Rockatanskaya, Lyudmila Alekseevna Sytova. Synthesis of the matrix metalloproteinases and its inhibitors by peripheral blood phagocytes of women with hypertansion disorders. Journal of obstetrics and women's diseases, 2015, 64(3): 26-32 DOI:10.17816/JOWD64326-32

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Айламазян Э. К., Мозговая Е. В. Гестоз: теория и практика. М.: МЕДпресс-информ; 2008.

[2]	Каспарова А. Э., Белоцерковцева Л. Д., Коваленко Л. В., Сус Л. А. Современные представления о патогенетических механизмах развития преэклампсии при беременности (обзор литературы). Вестник СурГУ. Медицина. 2011; 1 (7): 50-6.

[3]	Кудряшова А. В., Панова И. А., Хлипунова Д. А., Смирнова Е. В. Продукция провоспалительных цитокинов и изменение экспрессии молекул адгезии у беременных с гипертензивными нарушениями. Цитокины и воспаление. 2014; 13 (1): 103.

[4]	Лупач Н. М., Хлудеева Е. А., Потапов В. Н., Лукьянов П. А. Матриксные металлопротеиназы, оксидантный статус и дисфункция эндотелия у лиц с гиперхолестеринемией и у пациентов с различными формами ишемической болезни сердца. Тихоокеанский медицинский журнал. 2010; 4: 71-4.

[5]	Панова И. А., Кудряшова А. В., Хлипунова Д. А., Смирнова Е. В., Рокотянская Е. А. Характеристика зрелости и адгезионной способности нейтрофилов при преэклампсии. Российский иммунологический журнал. 2014; 8 (17): 360-63.

[6]	Посисеева Л. В., Сотникова Н. Ю., Панова И. А., Кудряшова А. В., Анциферова Ю. С., Кулида Л. В. Иммунные механизмы развития гестоза. Иваново; 2008.

[7]	Хлипунова Д. А., Панова И. А., Кудряшова А. В. Попова И. Г. Экспрессия молекул межклеточной адгезии и эндотелиальная дисфункция у беременных женщин с гипертензивными нарушениями. Мать и Дитя в Кузбассе. 2014; 2: 123-26.

[8]	Ab Hamid J., Mohtarrudin N., Osman M., Andi Asri A. A., Wan Hassan W. H., Aziz R. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension. Singapore Med Journal. 2012; 53 (10): 681-3.

[9]	Derosa G., D'Angelo A., Ciccarelli L., Piccinni M. N., Pricolo F., Salvadeo S., Montagna L., Gravina A., Ferrari I., Galli S., Paniga S., Tinelli C., Cicero A. F. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. 2006; 13 (3): 227-31.

[10]	Fernandez-Patron C., Radomski M. W., Davidge S. T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res. 1999; 85: 906-11.

[11]	Galewska Z., Romanowicz L., Jaworski S., Bankowski E. Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia. Clin Chem Lab Med. 2008; 46: 517-22.

[12]	Lavee M., Goldman S., Daniel-Spiegel E., Shalev E. Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia. Reprod Biol Endocrinol. 2009; 7:85.

[13]	Li Y. Q., Liu R., Xue J. H., Zhang Y., Gao D. F., Wu X. S., Wang C. X., Yang Y. B. Effects of monocyte-endothelium interactions on the expression of type IV collagenases in monocytes. Exp Ther Med. 2015; 9 (2): 527-32.

[14]	Myers J. E., Merchant S. J., Macleod M., Mires G. J., Baker P. N., Davidge S. T. MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia. Hypertens Pregnancy. 2005; 24: 103-15.

[15]	Palei A. C., Sandrim V. C., Duarte G., Cavalli R. C., Gerlach R. F., Tanus-Santos J. E. Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. Clin Chim Acta. 2010; 411 (11-12): 874-7.

[16]	Poon L. C., Nekrasova E., Anastassopoulos P., Livanos P., Nicolaides K. H. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn. 2009; 29: 553-9.

[17]	Raffetto J. D., Ross R. L., Khalil R. A. Matrix metalloproteinase-2 induced venous dilation via hyperpolarization and activation of K+ channels: Relevance to varicose vein formation. J. Vasc Surg. 2007; 45: 373-80.

[18]	Tayebjee M. H., Karalis I., Nadar S. K., Beevers D. G., MacFadyen R. J., Lip G. Y. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. Journal of Hypertension. 2005; 18 (3): 325-9.